Letter: ustekinumab dose intensification for loss of response—should we re-induce before shortening the dose interval? Author's reply

Uri Kopylov*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)565-566
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Issue number3
StatePublished - 1 Aug 2020
Externally publishedYes

Cite this